Programme by day

Saturday 3rd of September 2011
09:00-12:30		PHARMACOVIGILANCE AND MEDICINES INFORMATION TO ENHANCE PATIENT SAFETY R1
13:30-17:15		PHARMACOVIGILANCE AND MEDICINES INFORMATION TO ENHANCE PATIENT SAFETY R1
Monday 5th of September 2011
09:00-12:00		A PRIMER ON QUALITY AND SAFETY A1
		BUILDING PRACTITIONER SKILLS J1
		COMMUNITY PHARMACY BUSINESS MODELS: BUSINESS AND FINANCIAL ASPECTS OF IMPLEMENTING AND INTEGRATING PHARMACEUTICAL SERVICES - INTEGRATING PROFESSIONAL SERVICES WITH THE BUSINESS OF A PHARMACY (FORUM FOR INNOVATORS IN PHARMACY PRACTICE) (PART 1) D1
		PHARMACOGENOMICS IN ONCOLOGY J4
		REGULATORY AND LEGISLATIVE CHANGES IN PHARMACY FROM ACROSS THE WORLD J3
		WHO GUIDELINES ON MULTISOURCE DRUGS AND INTERCHANGEABILITY C1
		YOUR CAREER IN INDUSTRIAL PHARMACY - FROM DRUG DEVELOPMENT TO DRUG DISTRIBUTION J2
12:15-13:45		CAREERS AND LEADERSHIP IN PHARMACY AND EDUCATION F1
		FIP MEMBER ORGANISATIONS PRESENTING NATIONAL UPDATES (PART 1) F9
14:00-17:00		CAREERING TOWARD ADVANCED LEVELS OF PRACTICE J5
		CLINICAL BIOLOGY IN INDIA HEALTH CARE SYSTEM: ORGANISATION AND CONTRIBUTION D3
		COMMUNICATING BASIC MEDICINES INFORMATION TO PATIENTS J6
		COMMUNITY PHARMACY BUSINESS MODELS: BUSINESS AND FINANCIAL ASPECTS OF IMPLEMENTING AND INTEGRATING PHARMACEUTICAL SERVICES - INTEGRATING PROFESSIONAL SERVICES WITH THE BUSINESS OF A PHARMACY (FORUM FOR INNOVATORS IN PHARMACY PRACTICE) (PART 2) D2
		GENERICS AND THE PATIENT EXPERIENCE: THE PHARMACIST’S ROLE IN ENSURING SAFE AND EFFECTIVE MEDICINES USE F2
15:00-18:00		BIOSIMILARS C2
		ENVIRONMENT AND PHARMACEUTICALS B1
Tuesday 6th of September 2011
09:00-12:00		CLINICAL RESEARCH C3
		CURRENT ISSUES SESSION- VULNERABLE POPULATIONS: WHAT ARE THEIR MEDICINE/HEALTH INFORMATION NEEDS AND HOW CAN WE ADDRESS THESE NEEDS? D4
		F3 – FIP/WHO SYMPOSIUM ON ENGAGING PHARMACISTS IN TUBERCULOSIS CARE AND CONTROL F3
		LEARNING FROM ERRORS AND MONITORING SAFETY A2
		SOLVING PRACTICAL TABLETING PROBLEMS D5
		THE BASEL STATEMENTS IN DEVELOPING AND DEVELOPED COUNTRIES - WHAT ARE THE RIGHT INGREDIENTS? D6
		TRENDS IN COMMUNITY PHARMACY – DEBATING THE FUTURE OF THE PROFESSION: FORUM FOR POLICY MAKERS J7
12:15-13:45		A GLIMPSE OF COMMUNITY PHARMACY IN 2020 – DISCUSSION FORUM ON COMMUNITY PHARMACY 2020 D7
		FIP MEMBER ORGANISATIONS PRESENTING NATIONAL UPDATES (PART 2) F10
14:00-17:00		COMPETITION FOR THE BEST ORAL INDUSTRIAL PRESENTATION (SHORT ORAL COMMUNICATIONS) J8
		F12 - FIP SYMPOSIUM ON COUNTERFEIT MEDICINES F12
		MEDICATION SAFETY AND RISK MANAGEMENT D9
		OF THE PHARMACY EDUCATION TASKFORCE: A REPORT, REVIEW AND REFLECTION F5
		PARADIGM SHIFT IN DRUG DISCOVERY AND DEVELOPMENT C4
		RECENT ADVANCES AND CHALLENGES IN THE SAFE PREPARATION OF CYTOTOXIC AGENTS D10
		REPORT OF THE FIP WORKING GROUP ON OPTIMIZING THE ROLE OF PHARMACISTS IN IMPROVING MATERNAL, NEWBORN, AND CHILD HEALTH (MNCH) F4
Wednesday 7th of September 2011
09:00-12:00		BUILDING A SAFER SERVICE: TECHNIQUES AND TOOLS TO IMPROVE QUALITY AND SAFETY A3
		COMMUNICATION AND CONTROL IN AN OPERATIONAL SETTING D23
		INNOVATIONS TO IMPROVE TEACHING AND LEARNING D13
		MAPPING A NEW VISION - TRANSLATING IDEAS INTO PRACTICE F6
		PEDIATRIC MEDICINES - CHALLENGES AND OPPORTUNITIES J9
		PHARMACEUTICAL MANUFACTURING C5
		THE PRACTITIONERS’ DAY – PRACTICAL SOLUTIONS TO HEALTH PROBLEMS AND SERVICE PROVISION (PART I) D11
12:15-13:45		FIP MEMBER ORGANISATIONS PRESENTING NATIONAL UPDATES (PART 3) F11
14:00-17:00		BUILDING A 'TOOLBOX' FOR PRACTITIONER DEVELOPMENT AND SUPPORT J10
		PAYING PHARMACISTS FOR PATIENT OUTCOMES: PAY FOR PERFORMANCE A4
		PHARMACEUTICALS IN THE ENVIRONMENT J12
		QUALITY AND SAFETY IN PHARMACOLOGISTICS D14
		STANDARDIZATION OF HERBAL PRODUCTS C6
		THE PRACTITIONERS’ DAY – PRACTICAL SOLUTIONS TO HEALTH PROBLEMS AND SERVICE PROVISION (PART II) D12
Thursday 8th of September 2011
09:00-12:00		ASK YOUR PHARMACIST DAY (PART 1) IMMUNIZATIONS IN COMMUNITY PHARMACY – ASK YOUR PHARMACIST! D19
		ASPECTS OF MEDICATION AND PATIENT SAFETY - SOCIAL AND ADMINISTRATIVE PHARMACY SECTION CONTRIBUTED PAPERS [SHORT ORAL COMMUNICATIONS] D16
		DEVELOPING YOUNG ACADEMICS THROUGH NETWORKING AND MENTORING J13
		DISSOLUTION: THE PIVOTAL TOOL FOR DEVELOPING QUALITY DRUGS C7
		GOOD MANUFACTURING PRACTICES - EXPECTATIONS FOR THE COMING DECADE (PART I) D17
		PHARMACISTS AND MASS COMMUNICATION – A JOB THAT NEEDS TO BE DONE CONTINUOUSLY D15
		SYMPOSIUM ON THE HISTORY OF PHARMACY (PART 1) F7
		TACKLING PHARMACY LEADERSHIP AS A GLOBAL ISSUE D22
14:00-17:00		ASK YOUR PHARMACIST DAY (PART 2) HEALTHY TRAVELLING? – ASK YOUR PHARMACIST! D20
		CONTRIBUTED PAPERS -SHORT ORAL PRESENTATIONS OF THE FIP ACADEMIC PHARMACY SECTION D21
		GOOD MANUFACTURING PRACTICES - EXPECTATIONS FOR THE COMING DECADE (PART II) D18
		PHARMACOVIGILANCE: ENSURING SERIOUS MEDICATION SAFETY CONCERNS ARE RECOGNIZED, ADDRESSED, REPORTED AND MONITORED J14
		SYMPOSIUM ON THE HISTORY OF PHARMACY (PART 2) F8

We work with

» World Health Organization » UNESCO » World Health Professions Alliance » Regional Pharmaceutical Forums » All our partners

Shortcuts

» About FIP

Contact Details

FIP Congress Department

PO Box 84200

2508 AE The Hague

The Netherlands

Andries Bickerweg 5

2517 JP The Hague

The Netherlands

Email: congress@fip.org

Programme by day

Saturday 3rd of September 2011

Monday 5th of September 2011

Tuesday 6th of September 2011

Wednesday 7th of September 2011

Thursday 8th of September 2011

We work with

Shortcuts

Contact Details